Provided by Tiger Trade Technology Pte. Ltd.

Amgen

347.80
-2.1200-0.61%
Post-market: 348.000.2000+0.06%19:56 EDT
Volume:9.17M
Turnover:3.19B
Market Cap:187.28B
PE:24.44
High:351.25
Open:348.01
Low:344.95
Close:349.92
52wk High:391.29
52wk Low:261.43
Shares:538.48M
Float Shares:536.99M
Volume Ratio:4.17
T/O Rate:1.71%
Dividend:9.66
Dividend Rate:2.78%
EPS(TTM):14.23
EPS(LYR):14.23
ROE:106.10%
ROA:7.93%
PB:21.63
PE(LYR):24.44

Loading ...

Amgen Announces 2026 Second Quarter Dividend

THOMSON REUTERS
·
Mar 05

Amgen Inc - Declares Q2 2026 Dividend of $2.52 per Share

THOMSON REUTERS
·
Mar 05

Amgen Advances Blinatumomab Franchise With New Phase 3 Subcutaneous Trial

TIPRANKS
·
Mar 05

Kyowa Kirin Discontinues All Rocatinlimab Clinical Trials

Reuters
·
Mar 04

Caterpillar, Sherwin-Williams Co. Share Losses Contribute To Dow's Nearly 1200-Point Drop

Dow Jones
·
Mar 03

Kyowa Kirin: Recent Safety Review Done Over Last Several Weeks Found Emerging Concerns of Malignancies With Possible Viral or Immune-Related Links

THOMSON REUTERS
·
Mar 03

Amgen EVP of Operations Esteban Santos Disposes of Common Shares

Reuters
·
Mar 03

Amgen’s Phase 3 Gout Trial Pits Subcutaneous Pegloticase Against IV Dosing

TIPRANKS
·
Mar 03

Amgen Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 28

Amgen Fine-Tunes Evolocumab: New Bioavailability Study Signals Long-Term Cholesterol Franchise Focus

TIPRANKS
·
Feb 28

Amgen Nears a Nivolumab Biosimilar Milestone in Melanoma: What Investors Should Watch

TIPRANKS
·
Feb 28

Dow's 131-Point Fall Led By Losses In NVIDIA Corp., Caterpillar Shares

Dow Jones
·
Feb 27

Amgen to Present at TD Cowen Health Care Conference

Reuters
·
Feb 25

Lilly, Novo Shares Fall over 2% Each. Novo Nordisk to Cut U.S. List Prices for Ozempic, Wegovy by up to 50%

Dow Jones
·
Feb 24

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Reuters
·
Feb 24

Flagship-backed Generate Biomedicines eyes $2.2 billion valuation in US IPO

Reuters
·
Feb 23

Amgen VP, Finance & CAO Matthew C. Busch Disposes of Common Shares

Reuters
·
Feb 21

Amgen Initiated at Equal-Weight by Barclays

Dow Jones
·
Feb 20

Daiichi Sankyo Names John Tsai Global Head of R&D

Reuters
·
Feb 20

Amgen Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Feb 20